One study showed that treatment with a cis p-tau specific monoclonal antibody, clone #113, prevented tauopathy development, rescued neuronal and behavioral deficits, and reduced brain atrophy in a repeated CCI mouse injury model (144). This evidence concerns the gene MAPT and tauopathy.